References

References 1. Rosenbaum JF, Pollack MH, Otto MW, Bernstein JG. Anxious patients, in Cassem NH, Stern TA, Rosenbaum JF, Jellinek MS (eds): Massachusetts General Hospital Handbook of General Psychiatry. St. Louis, Mosby-Year Book, 1997, ed 4, pp 173–210. 2. Lewis S. Anxiety, in Harkreader H (ed): Fundamentals of Nursing: Caring and Clinical Judgment. Philadelphia, W.B. Saunders Co., 2000, pp 1310–1328. 3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC, American Psychiatric Association, 2000, ed 4 text rev, pp 436–476. 4. Wittchen HU, Hoyer J. Generalized anxiety disorder: Nature and course. J Clin Psychiatry 2001; 62( Suppl 11): 15–19.WittchenHU]]HoyerJGeneralized anxiety disorder: Nature and courseJ Clin Psychiatry20016215 5. Carter RM, Wittchen HU, Phister H, Kessler RC. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety 2001; 13: 78–88.CarterRM]]WittchenHU]]PhisterH]]KesslerRCOne-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sampleDepress Anxiety20011378 6. Olfson M, Broadhead WE, Weissmann MM, Leon AC, Farber L, Hoven C, et al. Subthreshold psychiatric symptoms in a primary care group practice. Arch Gen Psychiatry 1996; 53: 880–886.OlfsonM]]BroadheadWE]]WeissmannMM]]LeonAC]]FarberL]]HovenCSubthreshold psychiatric symptoms in a primary care group practiceArch Gen Psychiatry199653880 7. Dugas MJ, Gagnon F, Ladouceur R, Freeston MH. Generalized anxiety disorder: A preliminary test of a conceptual model. Behav Res Ther 1998; 36: 215–226.DugasMJ]]GagnonF]]LadouceurR]]FreestonMHGeneralized anxiety disorder: A preliminary test of a conceptual modelBehav Res Ther199836215 8. Nutt DJ. Neurobiological mechanisms in generalized anxiety disorder. J Clin Psychiatry 2001; 62( Suppl l1): 22–27.NuttDJNeurobiological mechanisms in generalized anxiety disorderJ Clin Psychiatry20016222 9. Krystal JH, D'Souza DC, Sanacora G, Goddard AW, Charney DS. Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders. Med Clin North Am 2001; 85: 559–577.KrystalJH]]D'SouzaDC]]SanacoraG]]GoddardAW]]CharneyDSCurrent perspectives on the pathophysiology of schizophrenia, depression, and anxiety disordersMed Clin North Am200185559 10. Nutt DJ, Glue P, Lawson C, Wilson S. Flumazenil provocation of panic attacks: Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 1990; 47: 917–925.NuttDJ]]GlueP]]LawsonC]]WilsonSFlumazenil provocation of panic attacks: Evidence for altered benzodiazepine receptor sensitivity in panic disorderArch Gen Psychiatry199047917 11. Davis M, Rainnie D, Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 1994; 17: 208–214.DavisM]]RainnieD]]CassellMNeurotransmission in the rat amygdala related to fear and anxietyTrends Neurosci199417208 12. Bradwejn J. CCK agonists and antagonists in clinical studies of panic and anxiety. Clin Neuropharmacol 1992; 15: 481A–482A.BradwejnJCCK agonists and antagonists in clinical studies of panic and anxietyClin Neuropharmacol199215481A 13. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, et al. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997; 154: 624–629.BremnerJD]]LicinioJ]]DarnellA]]KrystalJH]]OwensMJ]]SouthwickSMElevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorderAm J Psychiatry1997154624 14. Reynolds CF III, Shaw DH, Newton TF, Coble PA, Kupfer DJ. EEG sleep in outpatients with generalized anxiety: A preliminary comparison with depressed outpatients. Psychiatry Res 1983; 8: 81–89.ReynoldsCF]]ShawDH]]NewtonTF]]CoblePA]]KupferDJEEG sleep in outpatients with generalized anxiety: A preliminary comparison with depressed outpatientsPsychiatry Res1983881 15. Saletu-Zyhlarz G, Saletu B, Anderer P, Brandstatter N, Frey R, Gruber G, et al. Nonorganic insomnia in generalized anxiety disorder. 1. controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology 1997; 36: 117–129.Saletu-ZyhlarzG]]SaletuB]]AndererP]]BrandstatterN]]FreyR]]GruberGNonorganic insomnia in generalized anxiety disorder. 1. controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mappingNeuropsychobiology199736117 16. Thase ME, Simons AD, Reynolds CF III. Abnormal electroencephalographic sleep profiles in major depression: Association with response to cognitive behavior therapy. Arch Gen Psychiatry 1996; 53: 99–108.ThaseME]]SimonsAD]]ReynoldsCFAbnormal electroencephalographic sleep profiles in major depression: Association with response to cognitive behavior therapyArch Gen Psychiatry19965399 17. Gratacos M, Nadal M, Martin-Santos R, Pujana MA, Gago J, Peral B, et al. A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 2001; 106: 367–379.GratacosM]]NadalM]]Martin-SantosR]]PujanaMA]]GagoJ]]PeralBA polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disordersCell2001106367 18. Rickels K, Rynn MA. What is generalized anxiety disorder? J Clin Psychiatry 2001; 62( Suppl 11): 4–12.RickelsK]]RynnMAWhat is generalized anxiety disorder?J Clin Psychiatry2001624 19. Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen HU, Kunovac JL. Comorbidity as a fundamental feature of generalized anxiety disorders: Results from the National Comorbidity Study (NCS). Acta Psychiatr Scand Suppl 1998; 393: 6–11.JuddLL]]KesslerRC]]PaulusMP]]ZellerPV]]WittchenHU]]KunovacJLComorbidity as a fundamental feature of generalized anxiety disorders: Results from the National Comorbidity Study (NCS)Acta Psychiatr Scand Suppl19983936 20. Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 355–364.WittchenHU]]ZhaoS]]KesslerRC]]EatonWWDSM-III-R generalized anxiety disorder in the National Comorbidity SurveyArch Gen Psychiatry199451355 21. Lenze EJ, Mulsant BH, Shear MK, Schulberg HC, Dew MA, Begley AE, et al. Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry 2000; 157: 722–728.LenzeEJ]]MulsantBH]]ShearMK]]SchulbergHC]]DewMA]]BegleyAEComorbid anxiety disorders in depressed elderly patientsAm J Psychiatry2000157722 22. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000; 157: 669–682.MendlowiczMV]]SteinMBQuality of life in individuals with anxiety disordersAm J Psychiatry2000157669 23. Ballenger. Treatment of anxiety disorders to remission. J Clin Psychiatry 2001; 62( Suppl 12): 5–9.BallengerTreatment of anxiety disorders to remissionJ Clin Psychiatry2001625 24. Silverman WK, Saavedra LM, Pina AA. Test-retest reliability of anxiety symptoms and diagnosis with the Anxiety Disorders Interview Schedule for DSM-IV: Child and parent versions. J Am Acad Child Adolesc Psychiatry 2001; 40: 937–944.SilvermanWK]]SaavedraLM]]PinaAATest-retest reliability of anxiety symptoms and diagnosis with the Anxiety Disorders Interview Schedule for DSM-IV: Child and parent versionsJ Am Acad Child Adolesc Psychiatry200140937 25. Borkovec TD, Ruscio AM. Psychotherapy for generalized anxiety disorder. J Clin Psychiatry 2001; 62( Suppl 11): 37–45.BorkovecTD]]RuscioAMPsychotherapy for generalized anxiety disorderJ Clin Psychiatry20016237 26. Lenz G, Dermal U. Quality of life in depression and anxiety disorders: An exploratory follow-up study after intensive inpatient cognitive behavior therapy. Ps ychopathology 2000; 33: 297–302.LenzG]]DermalUQuality of life in depression and anxiety disorders: An exploratory follow-up study after intensive inpatient cognitive behavior therapyPsychopathology200033297 27. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001; 58: 55–61.YoungAS]]KlapR]]SherbourneCD]]WellsKBThe quality of care for depressive and anxiety disorders in the United StatesArch Gen Psychiatry20015855 28. Salzman C, Goldenberg I, Bruce SE, Keller MB. Pharmacologic treatment of anxiety disorders in 1989 versus 1996: Results from the Harvard/Brown anxiety disorders research program. J Clin Psychiatry 2001; 62: 149–152.SalzmanC]]GoldenbergI]]BruceSE]]KellerMBPharmacologic treatment of anxiety disorders in 1989 versus 1996: Results from the Harvard/Brown anxiety disorders research programJ Clin Psychiatry200162149 29. Davidson JRT. Pharmacotherapy of generalized anxiety disorder. J Clin Psychiatry 2001; 2( Suppl 11): 46–50.DavidsonJRTPharmacotherapy of generalized anxiety disorderJ Clin Psychiatry2001246 30. Lydiard RB, Laraia MT, Ballenger JC, Howell EF. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry 1987; 144: 664–665.LydiardRB]]LaraiaMT]]BallengerJC]]HowellEFEmergence of depressive symptoms in patients receiving alprazolam for panic disorderAm J Psychiatry1987144664 31. Rickels K, Downing R, Schweizer E, Hassman H. Antidepressants for the treatment of generalized anxiety disorder: A placebo-controlled comparison of imipramine, trazodone and diazepam. Arch Gen Psychiatry 1993; 50: 884–895.RickelsK]]DowningR]]SchweizerE]]HassmanHAntidepressants for the treatment of generalized anxiety disorder: A placebo-controlled comparison of imipramine, trazodone and diazepamArch Gen Psychiatry199350884 32. Davidson JR, DuPont RL, Hedges D, Haskins JT. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 1999; 60: 528–535.DavidsonJR]]DuPontRL]]HedgesD]]HaskinsJTEfficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorderJ Clin Psychiatry199960528 33. Rocca P, Fonzo V, Scotta M, Zanalda E, Ravizza L. Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997; 95: 444–450.RoccaP]]FonzoV]]ScottaM]]ZanaldaE]]RavizzaLParoxetine efficacy in the treatment of generalized anxiety disorderActa Psychiatr Scand199795444 34. Wylie ME, Miller MD, Shear MK, Little JT, Mulsant BH, Pollock BG, et al. Fluvoxamine pharmacotherapy of anxiety disorders in later life: Preliminary open-trial data. J Geriatr Psychiatry Neurol 2000; 13: 43–48.WylieME]]MillerMD]]ShearMK]]LittleJT]]MulsantBH]]PollockBGFluvoxamine pharmacotherapy of anxiety disorders in later life: Preliminary open-trial dataJ Geriatr Psychiatry Neurol20001343 35. Williams T, Hodgman C. Medication for the management of anxiety disorders in children and adolescents. Pediatr Ann 2001; 30: 146–153.WilliamsT]]HodgmanCMedication for the management of anxiety disorders in children and adolescentsPediatr Ann200130146 36. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001; 344: 1279–1285, 1326–1327.The Research Unit on Pediatric Psychopharmacology Anxiety Study GroupFluvoxamine for the treatment of anxiety disorders in children and adolescentsN Engl J Med20013441279 37. Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. JAMA 2000; 283: 3082–3088.GelenbergAJ]]LydiardRB]]RudolphRL]]AguiarL]]HaskinsJT]]SalinasEEfficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trialJAMA20002833082 38. Eison AS, Eison MS. Serotonergic mechanisms in anxiety. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 47–62.EisonAS]]EisonMSSerotonergic mechanisms in anxietyProg Neuropsychopharmacol Biol Psychiatry19941847 39. Norton JW, Quarles E. Gabapentin and anxiety. Hosp Pharm 2001; 36: 843–845.NortonJW]]QuarlesEGabapentin and anxietyHosp Pharm200136843 40. McEvoy GK. AHFS Drug Information 2001. Bethesda, MD, American Society of Health-System Pharmacists, 2001, pp 2094–2097. 41. Chouinard G, Beauclair L, Bélanger MC. Gabapentin: Long-tern antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders. Can J Psychiatry 1998; 43: 305.ChouinardG]]BeauclairL]]BélangerMCGabapentin: Long-tern antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disordersCan J Psychiatry199843305 &NA; Courage is doing what you're afraid to do.There is no courage unless you're scared.—Eddie Rickenbacker